Management of Streptococcus gallolyticus Bacteremia and Infective Endocarditis

Screening for Colorectal Neoplasia

All adults with S. gallolyticus bacteremia or infective endocarditis should undergo colonoscopic evaluation because 25 %–80 % have concurrent colorectal cancer or premalignant lesions. 1

Native‑valve endocarditis – Penicillin G monotherapy: 24 million units IV per 24 h (continuous infusion or 4–6 divided doses) for 4 weeks yields bacteriological cure rates of ≥98 %. 1
Native‑valve endocarditis – Ceftriaxone monotherapy: 2 g IV once daily for 4 weeks provides efficacy equivalent to Penicillin G and is logistically simpler for outpatient care. 2
Shortened 2‑week regimen (uncomplicated cases): Penicillin G or Ceftriaxone combined with Gentamicin 3 mg/kg IV once daily for a total of 2 weeks is reasonable when renal function (creatinine clearance > 20 mL/min) is adequate and no extracardiac infection is present. This option is supported by moderate‑quality evidence. 3

Standard course: Penicillin G 24 million units/24 h IV or Ceftriaxone 2 g IV daily for 6 weeks; Gentamicin 3 mg/kg daily may be added for the first 2 weeks at the clinician’s discretion. 4
Positive intra‑operative valve cultures: After valve replacement, a full antimicrobial course should be restarted regardless of prior therapy duration. 5

Native‑valve endocarditis: Penicillin G or Ceftriaxone for 4 weeks plus Gentamicin 3 mg/kg IV once daily for the first 2 weeks. 6
Prosthetic‑valve endocarditis: Same β‑lactam regimen for 6 weeks plus Gentamicin 3 mg/kg IV daily for the entire 6‑week period. 4

Vancomycin monotherapy: 30 mg/kg/24 h IV divided into two doses for 4 weeks (native valve) or 6 weeks (prosthetic valve). 2
Vancomycin should be reserved only when β‑lactam agents cannot be used (e.g., documented allergy). 3
Avoid adding Gentamicin to Vancomycin: No demonstrated benefit and increased risk of nephro‑ and ototoxicity; classified as a Class III (harm) recommendation. 6

Counting treatment days: Begin the clock on the first day blood cultures become negative, not on the day antibiotics are started. 1
Uncomplicated bacteremia without endocarditis: Minimum of 2 weeks after culture clearance. 1
Native‑valve endocarditis (highly susceptible): Standard 4‑week course; a 2‑week regimen with Gentamicin is acceptable only for uncomplicated infections. 2
Prosthetic‑valve endocarditis: Minimum 6 weeks of therapy. 4
Post‑surgical with negative valve cultures: Pre‑operative treatment days may be counted toward the total; some data suggest that an additional 2 weeks after surgery may be sufficient. 5
Post‑surgical with positive valve cultures: Complete a full antimicrobial course after the operation. 5

Obtain at least two sets of blood cultures every 24–48 hours until bloodstream infection clears. 1
Document clearance of bacteremia 2–4 days after the initial positive cultures before making any treatment modifications. 5

Do not use Vancomycin when a β‑lactam (Penicillin G or Ceftriaxone) is appropriate; this increases nephrotoxicity, thrombophlebitis, and is associated with inferior outcomes. 2
Do not add Gentamicin to Vancomycin in β‑lactam‑intolerant patients; this is a Class III (harm) recommendation. 6
Do not apply the 2‑week shortened regimen in patients with creatinine clearance < 20 mL/min, extracardiac infection, or complicated endocarditis. 3
Do not omit colonoscopy even if recent screening was negative; the high prevalence (25 %–80 %) of colorectal pathology mandates evaluation. 1
Do not discharge patients on oral antibiotics before completing the full parenteral course; intravenous therapy is required for the entire prescribed duration. 2

Obtain an infectious disease specialist consultation at the time of empirical therapy initiation to optimize antimicrobial selection and treatment duration. 5